Bcl-2-IN-7 is a potent Bcl-2 (B-cell lymphoma-2) inhibitor that downregulates Bcl-2 expression and upregulates the expression of p53, Bax, and caspase-7 mRNA. It induces cell cycle arrest and apoptosis in breast cancer MCF-7 cells. Bcl-2-IN-7 exhibits potent antitumor activity against MCF-7, LoVo, HepG2, and A549 cells, with IC50 values of 20.91, 22.30, 42.29, and 48.00 μM, respectively.